NSE: COLPAL | BSE: 500830

Expensive Performer

Download real time

2106.70 10.20 (0.49%)

New 52W Low in past week

561.8K NSE+BSE Volume

NSE 13 Jan, 2026 3:31 PM (IST)

57,299.2

Market Cap

High in industry

Beta 1Year

Very Low volatility

Colgate-Palmolive (India) Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for COLPAL, BSE:500830 Colgate-Palmolive (India) Ltd.

Search Inside the pdf :

Colgate-Palmolive (India) Ltd.

06 Nov 2025

2106.70

0.49%

COLGATE PALMOLIVE INDIA LTD

Buy: Colgate-Palmolive (India) ...

Recommendation Target

Geojit BNP Paribas

Colgate's revenue fell during the quarter due to temporary distribution disruptions following the revision in GST rates on oral care portfolio. However, its business fundamentals remained strong with continued brand investments and steady demand in premium segments. The company's strategic focus on innovation, product diversification and rural penetration is expected to aid recovery in the second half of FY26. Ongoing cost optimization under the funding the growth' program, coupled with innovation-led launches in oral and personal care should...

Number of FII/FPI investors decreased from 797 to 750 in Dec 2025 qtr

Colgate-Palmolive (India) Ltd.

24 Oct 2025

2106.70

0.49%

Sales decline amid GST-led distribution disruption.

Accumulate: Colgate-Palmolive (India) ...

Target

Deven Choksey

Management expects a gradual demand recovery in H2FY26E, supported by improving macro indicators and internal execution initiatives.

Colgate-Palmolive (India) Ltd. is trading below all available SMAs

Colgate-Palmolive (India) Ltd.

24 Oct 2025

2106.70

0.49%

Result Update:Colgate-Palmoliv

Buy: Colgate-Palmolive (India) ...

Target

Axis Direct

With an upside of 12% from the CMP, we maintain our BUY rating on the stock

Colgate-Palmolive (India) Ltd. is trading below all available SMAs

Colgate-Palmolive (India) Ltd.

24 Oct 2025

2106.70

0.49%

Same story. SELL

Sell: Colgate-Palmolive (India) ...

ICICI Securities Limited

Colgate’s Q2FY26 result reaffirms that business remains structurally fatigued, with no visible triggers for a turnaround. Revenue declined 6.2% YoY, implying a 7-8% volume decline amid GST-led destocking and continued competitive intensity.

Colgate-Palmolive (I.. has an average target of 2488.57 from 7 brokers.

Colgate-Palmolive (India) Ltd.

23 Oct 2025

2106.70

0.49%

Muted 2Q print; watchful for growth recovery ahead

Buy: Colgate-Palmolive (India) ...

Recommendation Target

Motilal Oswal

Colgate’s (CLGT) 2QFY26 performance remained weak as its revenue fell 6% YoY to INR15.2b (in line) on a high base of 10% growth and due to the impact of GST-led transition (trade disruptions).

Number of FII/FPI investors decreased from 797 to 750 in Dec 2025 qtr

Colgate-Palmolive (India) Ltd.

23 Oct 2025

2106.70

0.49%

Colgate Palmolive (CLGT IN) Q2FY26 Result Update Competitive...

Hold: Colgate-Palmolive (India) ...

Target

Prabhudas Lilladhar

Number of FII/FPI investors decreased from 797 to 750 in Dec 2025 qtr

Colgate-Palmolive (India) Ltd.

05 Sep 2025

2106.70

0.49%

Company Update:Colgate-Palmoliv

Buy: Colgate-Palmolive (India) ...

Target

Axis Direct

Maintain BUY ratings on with a revised TP at Rs 2,780.

Number of FII/FPI investors decreased from 797 to 750 in Dec 2025 qtr

Colgate-Palmolive (India) Ltd.

25 Jul 2025

2106.70

0.49%

Urban demand impacted growth; a gradual recovery is expected from H2FY26E

Accumulate: Colgate-Palmolive (India) ...

Deven Choksey

Colgate Palmolive India’s Q1FY26 performance stood below our expectations across the board, reflecting persistent headwinds from tough operating conditions led by muted urban demand and elevated competition intensity.

Colgate-Palmolive has lost -25.58% in the last 1 Year

Colgate-Palmolive (India) Ltd.

23 Jul 2025

2106.70

0.49%

Result Update:Colgate-Palmoliv

Buy: Colgate-Palmolive (India) ...

Recommendation Target

Axis Direct

With an upside of 12% from the CMP, we maintain our BUY rating on the stock.

Colgate-Palmolive (India) Ltd. is trading below all available SMAs

Colgate-Palmolive (India) Ltd.

22 Jul 2025

2106.70

0.49%

Colgate Palmolive (CLGT IN) Q1FY26 Result Update Urban...

Hold: Colgate-Palmolive (India) ...

Target

Prabhudas Lilladhar

We cut FY26/27 EPS by 7.1/7.4% given subdued urban demand, competitive pressures and little scope to increase margins from current elevated levels. CLGT 1Q26 was a miss on estimates with 4.4% revenue decline led by 2.8% volume decline (high base, subdued urban demand and intensifying competitive pressures). Near term outlook remains cautious as impact of high base, tepid urban demand, heightened competition and promotions/...

Colgate-Palmolive has lost -25.58% in the last 1 Year

Is Colgate-Palmolive (India) Ltd. worth buying?

428 Votes:

Buy 77.57%

Sell 13.08%

Hold 9.35%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Sell SEE REPORTS >

pdf